Molecular Biomedicine (Nov 2023)

MSCs overexpressing GDNF restores brain structure and neurological function in rats with intracerebral hemorrhage

  • Xiaoqian Jiang,
  • Ling Zhou,
  • Zihuan Sun,
  • Bingqing Xie,
  • Heng Lin,
  • Xiaoqing Gao,
  • Li Deng,
  • Chaoxian Yang

DOI
https://doi.org/10.1186/s43556-023-00159-7
Journal volume & issue
Vol. 4, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Mesenchymal stem cells (MSCs) have been applied in transplantation to treat intracerebral hemorrhage (ICH) but with limited efficacy. Accumulated evidence has shown that glial cell-derived neurotrophic factor (GDNF) plays a crucial part in neuronal protection and functional recovery of the brain after ICH; however, GDNF has difficulty crossing the blood–brain barrier, which limits its application. In this study, we investigated the influences of MSCs overexpressing GDNF (MSCs/GDNF) on the brain structure as well as gait of rats after ICH and explored the possible mechanisms. We found that cell transplantation could reverse the neurological dysfunction and brain damage caused by ICH to a certain extent, and MSCs/GDNF transplantation was superior to MSCs transplantation. Moreover, Transplantation of MSCs overexpressing GDNF effectively reduced the volume of bleeding foci and increased the level of glucose uptake in rats with ICH, which could be related to improving mitochondrial quality. Furthermore, GDNF produced by transplanted MSCs/GDNF further inhibited neuroinflammation, improved mitochondrial quality and function, promoted angiogenesis and the survival of neurons and oligodendrocytes, and enhanced synaptic plasticity in ICH rats when compared with simple MSC transplantation. Overall, our data indicate that GDNF overexpression heightens the curative effect of MSC implantation in treating rats following ICH.

Keywords